Cargando...
Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer
Immunotherapy using immune checkpoint inhibitors has opened a new era for cancer management. In colorectal cancer, patients with a phenotype of deficient mismatch repair or high microsatellite instability benefit from immunotherapy. However, the response of rest cases to immunotherapy alone is still...
Guardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466849/ https://ncbi.nlm.nih.gov/pubmed/32934878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1773205 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|